Incyte
INCY
#1037
Rank
โ‚น2.218 T
Marketcap
โ‚น10,945
Share price
0.33%
Change (1 day)
44.26%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2026 (TTM): โ‚น748.49

According to Incyte's latest financial reports the company's current EPS (TTM) is โ‚น786.66. In 2025 the company made an earnings per share (EPS) of โ‚น638.62 an increase over its 2024 EPS that were of โ‚น30.00.

EPS history for Incyte from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น748.4917.21%
2025โ‚น638.622029.03%
2024โ‚น30.00-88.39%
2023โ‚น258.3573.38%
2022โ‚น149.01-64.1%
2021โ‚น415.10-408.63%
2020-โ‚น134.50-166.83%
2019โ‚น201.26300%
2018โ‚น50.32-133.33%
2017-โ‚น150.95-378.57%
2016โ‚น54.192700%
2015โ‚น1.94-106.67%
2014-โ‚น29.03-44.44%
2013-โ‚น52.2550%
2012-โ‚น34.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
โ‚น644.42-18.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น73.54-90.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,892 267.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,569 99.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น968.57 23.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น10.64-101.35%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น56.12-107.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚น81.28-110.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚น21.29-102.71%๐Ÿ‡บ๐Ÿ‡ธ USA